Do platelet-derived microparticles play a role in depression, inflammation, and acute coronary syndrome?

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Psychosomatics

• Publication date

  2014-05-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.psym.2013.09.004PMID 24374086PMCID PMC4004656
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Psychometrics of the PHQ-9 as a measure of depressive symptoms in patients with heart failure

  2013cited by this paper
• Platelet-derived microparticles during and after acute coronary syndrome

  2012cited by this paper
• Changes in plasma and platelet BDNF levels induced by S-citalopram in major depression

  2011cited by this paper
• Measuring depression severity in general practice: discriminatory performance of the PHQ-9, HADS-D, and BDI-II.

  2011cited by this paper
• Clinical relevance of microparticles from platelets and megakaryocytes

  2010cited by this paper
• Altered nitric oxide/cGMP platelet signaling pathway in platelets from patients with acute coronary syndromes

  2010cited by this paper
• Microparticles: Protagonists of a Novel Communication Network for Intercellular Information Exchange

  2010cited by this paper
• Depression and Whole Blood Serotonin in Patients With Coronary Heart Disease From the Heart and Soul Study

  2009cited by this paper
• Associations of Depression With C-Reactive Protein, IL-1, and IL-6: A Meta-Analysis

  2009cited by this paper
• Depression and coronary heart disease: recommendations for screening, referral, and treatment: a science advisory from the American Heart Association Prevention Committee of the Council on Cardiovascular Nursing, Council on Clinical Cardiology, Council on Epidemiology and Prevention, and Interdiscip

  2008cited by this paper
• Inflammatory markers, angiographic severity of coronary artery disease, and patient outcome.

  2007cited by this paper
• The prevalence of unrecognized depression in patients with acute coronary syndrome.

  2006cited by this paper
• Circulating microparticles: a potential prognostic marker for atherosclerotic vascular disease.

  2006cited by this paper
• Evaluation of platelet function in aspirin treated patients with CAD

  2006cited by this paper
• Depression following myocardial infarction.

  2005cited by this paper
• Depression, alterations in platelet function, and ischemic heart disease.

  2005cited by this paper
• Exaggerated serotonin-mediated platelet reactivity as a possible link in depression and acute coronary syndromes.

  2002cited by this paper
• The PHQ-9: validity of a brief depression severity measure.

  2001cited by this paper
• Even minimal symptoms of depression increase mortality risk after acute myocardial infarction.

  2001cited by this paper
• Platelet activation in depression and effects of sertraline treatment: An open-label study.

  2000cited by this paper
• Platelet reactivity in depressed patients treated with paroxetine: preliminary findings.

  2000cited by this paper
• Markers of myocardial damage and inflammation in relation to long-term mortality in unstable coronary artery disease. FRISC Study Group. Fragmin during Instability in Coronary Artery Disease.

  2000cited by this paper
• Evaluation of platelet activation in depressed patients with ischemic heart disease after paroxetine or nortriptyline treatment.

  2000cited by this paper
• Elevated levels of shed membrane microparticles with procoagulant potential in the peripheral circulating blood of patients with acute coronary syndromes.

  2000cited by this paper
• Treatment of unstable angina: the role of platelet inhibitors and anticoagulants.

  1999cited by this paper
• Elevated platelet factor 4 and beta-thromboglobulin plasma levels in depressed patients with ischemic heart disease.

  1997cited by this paper
• Exaggerated platelet reactivity in major depression.

  1996cited by this paper
• Depression following myocardial infarction. Impact on 6-month survival.

  1993cited by this paper
• Depression following Myocardial Infarction

  1992cited by this paper
• Plaque disruption and the acute coronary syndromes of unstable angina and myocardial infarction: if the substrate is similar, why is the clinical presentation different?

  1992cited by this paper
• Alpha 2-adrenoceptor-mediated inhibition of platelet adenylate cyclase and induction of aggregation in major depression. Effect of long-term cyclic antidepressant drug treatment.

  1990cited by this paper
• Enhanced alpha 2-adrenoceptor-mediated platelet aggregation in patients with major depressive disorder.

  1983cited by this paper
• Enhanced α2-adrenoceptor-mediated platelet aggregation in patients with major depressive disorder

  1983cited by this paper

• Role and Mechanism of Microglia in White Matter Injury Recovery in Ischemic Stroke

  2025cites this paper
• Complications and Healthcare Cost of Total Hip Arthroplasty in Patients with Depressive Disorder

  2024cites this paper
• Interactions between cadmium, lead, mercury, and arsenic and depression: A molecular mechanism involved.

  2023cites this paper
• INTERPLAY OF INFLAMMATORY BIOMARKERS IN HEART DISEASE PATIENTS WITH DEPRESSIVE SYMPTOMS: AN UPDATE.

  2023cites this paper
• Depression Following Acute Coronary Syndrome: A Review

  2023cites this paper
• Importance of depressive symptoms in patients with coronary heart disease - review article.

  2023cites this paper
• Methods to evaluate vascular function: a crucial approach towards predictive, preventive, and personalised medicine

  2022cites this paper
• The Vascular Endothelium and Coagulation: Homeostasis, Disease, and Treatment, with a Focus on the Von Willebrand Factor and Factors VIII and V

  2022cites this paper
• Depressive symptoms and inflammatory markers following acute myocardial infarction: A scoping review

  2022cites this paper
• NDT_A_315572 2315..2325

  2021cites this paper
• Сellular and Molecular Mechanisms of Proinflammatory Monocytes Participation in the Pathogenesis of Mental Disorders. Part 3

  2021cites this paper
• Acupuncture Treatment Reduced the Risk of Coronary Heart Disease in Patients with Depression: A Propensity-Score Matched Cohort Study

  2021cites this paper
• CD36+/CD61+ Microparticles Correlate with the Risk of Percutaneous Cardiac Interventions in Coronary Artery Disease Patients and the Effects of Ticagrelor

  2021cites this paper
• Association between depression and cardiorespiratory fitness in general population and patients with heart disease

  2020cites this paper
• Depression and myocardial injury in ST-segment elevation myocardial infarction: A cardiac magnetic resonance imaging study.

  2020cites this paper
• Protoilludane sesquiterpenoid aromatic esters from Armillaria mellea improve depressive-like behavior induced by chronic unpredictable mild stress in mice

  2020cites this paper
• Cell-derived Microparticles and Acute Coronary Syndromes: Is there a Predictive Role for Microparticles.

  2019cites this paper
• Antidepressant prescription in acute myocardial infarction is associated with increased mortality 1 year after discharge.

  2019cites this paper
• New Insights Into the Comorbidity of Coronary Heart Disease and Depression.

  2019cites this paper
• Platelet Microparticles: A Tool to Predict Infarction Area in Rats

  2019cites this paper
• Brain-Derived Microparticles (BDMPs) Contribute to Neuroinflammation and Lactadherin Reduces BDMP Induced Neuroinflammation and Improves Outcome After Stroke

  2019cites this paper
• DETERMINANT FACTORS OF DEPRESSION IN PATIENTS WITH CORONARY HEART DISEASE

  2019cites this paper
• Combined influence of depressive symptoms and systemic inflammation on all-cause and cardiovascular mortality: evidence for differential effects by gender in the English Longitudinal Study of Ageing

  2018cites this paper
• Characterisation of circulating extracellular vesicles in human obesity

  2018cites this paper
• Suppression of NLRP3 inflammasome attenuates stress-induced depression-like behavior in NLGN3-deficient mice.

  2018cites this paper
• Comparison of erythrocyte microparticle levels between acute coronary syndrome and stable angina pectoris patients

  2018cites this paper
• The potential role of exosomes in the diagnosis and therapy of ischemic diseases.

  2018cites this paper
• A Chronic State of Systemic Stress: The Link between Depression and Cardiovascular Disease?

  2017cites this paper
• Lifestyle Modification in Secondary Prevention

  2017cites this paper
• Protective effects of circulating microvesicles derived from myocardial ischemic rats on apoptosis of cardiomyocytes in myocardial ischemia/reperfusion injury

  2017cites this paper
• Depression In Myocardial Infarction Patients At Ayub Teaching Hospital Abbottabad.

  2017cites this paper
• Venous Thromboembolism Risk With Antidepressants: Driven by Disease or Drugs?

  2017cites this paper
• Protective effects of circulating microvesicles derived from myocardial ischemic rats on apoptosis of cardiomyocytes in myocardial ischemia/reperfusion injury.

  2017cites this paper
• Increased circulating leukocyte-derived microparticles in ischemic cerebrovascular disease.

  2017cites this paper
• Circulating Endothelial Microparticles: A Key Hallmark of Atherosclerosis Progression

  2016cites this paper
• Systematic Review/Meta-analysis Higher Plasma Concentrations of Platelet Microparticles in Patients With Acute Coronary Syndrome: A Systematic Review and Meta-analysis

  2016cites this paper
• Higher Plasma Concentrations of Platelet Microparticles in Patients With Acute Coronary Syndrome: A Systematic Review and Meta-analysis.

  2016cites this paper
• Potential Biomarkers for Depression Associated with Coronary Artery Disease: A Critical Review.

  2016cites this paper
• Expression of functional tissue factor in activated T-lymphocytes in vitro and in vivo: A possible contribution of immunity to thrombosis?

  2016cites this paper
• Endothelial Microparticles Act as Novel Diagnostic and Therapeutic Biomarkers of Diabetes and Its Complications: A Literature Review

  2016cites this paper
• The utility of inflammation and platelet biomarkers in patients with acute coronary syndromes

  2016cites this paper
• Microparticles as Novel Biomarkers and Therapeutic Targets in Coronary Heart Disease

  2015cites this paper
• Association of Leu125Val polymorphisms in the PECAM-1 gene with the risk of coronary heartdisease: a meta-analysis.

  2015cites this paper
• Mesenchymal Stem Cells Stabilize Atherosclerotic Vulnerable Plaque by Anti-Inflammatory Properties

  2015cites this paper
• Association of Leu 125 Val polymorphisms in the PECAM-1 gene with the risk of coronary heart disease : a meta-analysis

  2015cites this paper
• Microparticles as Potential Biomarkers of Cardiovascular Disease

  2015cites this paper
• Depression in People with Coronary Heart Disease: Prognostic Significance and Mechanisms

  2015cites this paper
• Brain changes associated with thromboxane receptor antagonist SQ 29,548 treatment in a mouse model

  2015cites this paper
• Platelet response to serotonin in patients with stable coronary heart disease.

  2014cites this paper